FIELD: molecular biology, biotechnology. SUBSTANCE: invention relates to recombinant protein-factor of inhibition of lipogenesis with molecular mass 23 kDa and DNA fragment nucleotide sequence encoding the obtained protein. Protein is produced by culturing mammalian cells COS-1 transformed with expression vector pSR-α-20-2 containing the known DNA fragment. Recombinant protein is used in composition showing the ability to inhibit lipogenesis. Invention provides the ability to carry out therapy and diagnosis of different cytopenias. EFFECT: protein-factor and DNA indicated above, valuable medicinal properties. 10 cl, 3 dwg, 9 tbl, 11 ex
Title |
Year |
Author |
Number |
DERIVATIVES OF FACTOR OF LIPOGENESIS INHIBITION AND THEIR PRODUCING |
1993 |
- Kendzi Mijadai
- Itiro Kavasima
- Dzun Okhsumi
- Jo Takiguti
- Jasukhiro Ito
|
RU2138554C1 |
POLYNUCLEOTIDE SEQUENCE (VARIANTS), POLYPEPTIDE (VARIANTS), FUSED PROTEIN, PHARMACEUTICAL COMPOSITION, MONOCLONAL ANTIBODY, STRAIN OF HYBRID CULTURED CELLS |
1995 |
- Tokhru Takakhasi
- Rjuta Koisi
- Itiro Kavasima
- Nobufuza Serizava
|
RU2143491C1 |
ANTI-ROBO4 ANTIBODY |
2013 |
- Isumi Joshitaka
- Sato Toshiyuki
- Khasegava Dzhun
- Inoue Tatsuya
|
RU2682451C2 |
NOVEL PROTEINS AND METHODS OF THEIR PREPARING |
1996 |
- Goto Masaaki
- Tsuda Ehjsuke
- Motizuki Siniti
- Jano Kazuki
- Kobajasi Fumie
- Sima Nobujuki
- Jasuda Khisataka
- Nakagava Nobuaki
- Morinaga Tomonori
- Ueda Masatsugu
- Khigasio Kandzi
|
RU2194714C2 |
PROTEIN BINDING SPECIFICALLY WITH OSTEOCLASTOGENESIS-INHIBITING FACTOR (OCIF) (VARIANTS), DNA ENCODING ITS (VARIANTS), DNA AS PROBE (VARIANTS), METHOD FOR PREPARING PROTEIN (VARIANTS), METHOD FOR SCREENING SUBSTANCE (VARIANTS), ANTIBODY (VARIANTS), METHOD FOR PREPARING POLYCLONAL ANTIBODY, HYBRIDOMA (VARIANTS), METHOD FOR PREPARING MONOCLONAL ANTIBODY, METHOD FOR ASSAY OF OCIF-BINDING PROTEIN, PHARMACEUTICAL COMPOSITION (VARIANTS) AND MEDICINAL AGENT (VARIANTS) |
1998 |
- Jamaguti Kiodzi
- Jasuda Khisataka
- Nakagava Nobuaki
- Sima Nobujuki
- Kinosaki Masakhiko
- Tsuda Eisuke
- Goto Masaaki
- Jano Kazuki
- Tomojasu Akikhiro
- Kobajasi Fumie
- Vasida Naokhiro
- Takakhasi Ken
- Morinaga Tomonori
- Khigasio Kandzi
|
RU2238949C2 |
DNA FRAGMENT, METHOD OF PRAVASTATIN SODIUM PREPARING, EXPRESSION PLASMID (VARIANTS), RECOMBINANT STRAIN (VARIANTS) |
1996 |
- Nobufusa Serizava
- Itiro Vatanabe
|
RU2140984C1 |
ANTIBODY DIRECTED ON SIGLEC-15 PROTEIN, BOUND WITH OSTEOCLASTS |
2008 |
- Khiruma Josikharu
- Tsuda Ejsuke
|
RU2475499C2 |
POLYNUCLEOTIDE ELICITING ABILITY TO ACCELERATE BIOSYNTHESIS OF PRAVASTATIN PRECURSOR ML-236B (VARIANTS), PLASMID EXPRESSION VECTOR, STRAIN PENICILLIUM CITRINUM (VARIANTS), STRAIN ESCHERICHIA COLI (VARIANTS), POLYPEPTIDE ACCELERATING BIOSYNTHESIS OF ML-236B (VARIANTS), PRAVASTATIN PRECURSOR ML-236B, METHOD FOR PREPARING PRAVASTATIN |
2001 |
- Esikava Khirodzi
- Abe Juki
- Ono Tikho
|
RU2236463C2 |
PROTEIN ABLE TO INHIBIT OSTEOCLASTOGENESIS (OCIF) (VARIANTS), CDNA, METHOD FOR PREPARING PROTEIN, METHOD FOR TREATMENT OF OSTEOPOROSIS, METHOD FOR TREATMENT AND/OR IMPROVEMENT OF BONE MASS RECOVERY, METHOD FOR TREATMENT OF INJURE ASSOCIATED WITH OSSEOUS METABOLISM, TRANSFORMED STRAIN ESCHERICHIA COLI PBK/01F10 AND PHARMACEUTICAL COMPOSITION |
1996 |
- Goto Masaaki
- Tsuda Ehjsuke
- Motizuki Siniti
- Jano Kazuki
- Kobajasi Fumie
- Sima Nobujuki
- Jasuda Khisataka
- Nakagava Nobuaki
- Morinaga Tomonori
- Ueda Masatsugu
- Khigasio Kandzi
|
RU2238948C2 |
ANTIBODY AGAINST TUMOR-SPECIFIC ANTIGENS AS TARGET |
2004 |
- Itikava Kimikhisa
- Takakhasi Su
- Agatsuma Tosinori
- Fukuti Kejsuke
- Khirai Takekhiro
|
RU2345090C2 |